Amino-terminus truncated apolipoprotein E is the major species in amyloid deposits in Alzheimer's disease-affected brains: A possible role for apolipoprotein E in Alzheimer's disease

Brain Research

Volumn 768, Issue 1-2, 1997, Pages 208-214

  Aizawa, Yuji ^a   Fukatsu, Ryo ^a   Takamaru, Yuji ^b   Tsuzuki, Kayo ^a   Chiba, Hitoshi ^c   Kobayashi, Kunihiko ^c   Fujii, Nobuhiro ^a   Takahata, Naohiko ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SAPPORO CITY GENERAL HOSPITAL   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Alzheimer's disease; Amyloid protein; Amyloid deposition; Apolipoprotein E; C terminus antibody; N terminus antibody

Indexed keywords

APOLIPOPROTEIN E;

ALZHEIMER DISEASE; AMINO TERMINAL SEQUENCE; AMYLOIDOSIS; ANTIBODY SPECIFICITY; ARTICLE; BRAIN DISEASE; CARBOXY TERMINAL SEQUENCE; COMPLEMENT ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; SENILE PLAQUE;

ALZHEIMER DISEASE; ANTIBODIES, MONOCLONAL; APOLIPOPROTEINS E; BLOTTING, WESTERN; BRAIN; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; HISTOCYTOCHEMISTRY; HUMANS; SENILE PLAQUES; THROMBIN;

EID: 0030863380     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00640-9     Document Type: Article

References (35)

1. Abe K., St. George-Hyslop P.H., Tanzi R.E., Kogure K. Induction of amyloid precursor protein mRNA after heat shock in cultured human lymphoblastoid cells. Neurosci. Lett. 125:1991;169-171.
2. 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease. Cell. 52:1988;487-501.
3. Y. Aizawa, R. Fukatsu, Y. Takamaru, K. Tsuzuki, T. Obara, M. Fujii, M. Kobayashi, N. Takahata, T. Gotoda, S. Nagasawa, K. Oguma, T. Kunishita, T. Tabira, Monoclonal antibodies against senile plaque amyloid in Alzheimer's disease, in: T. Nagatsu, A. Fisher, M. Yoshida (Eds.), Alzheimer's and Parkinson's Diseases, vol. 1, Basic, Clinical, and Therapeutic Aspects of Alzheimer's and Parkinson's Diseases, Plenum Press, New York, 1990, pp. 59-63.
4. Bradley W.A., Gilliam E.B., Gotto A.M., Gianturco S.H. Apolipoprotein-E degradation in human very low density lipoproteins by plasma protease(s): chemical and biological consequences. Biochem. Biophys. Res. Commun. 109:1982;1360-1367.
5. Castano E.M., Prelli F., Pras M., Frangione B. Apolipoprotein E carboxy-terminal fragments are complexed to amyloid A and L. J. Biol. Chem. 270:1995;17610-17615.
6. Choi-Miura N.H., Ihara Y., Fukuchi K., Takeda M., Nakano Y., Tobe T., Tomita M. SP-40,40 is a constituent of Alzheimer's amyloid. Acta Neuropathol. 83:1992;260-264.
7. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., Roses A.D., Haines J.L., Pericak-Vance M.A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 261:1993;921-923.
8. f 100-400 hypertriglyceridemic very low density lipoproteins by the low density lipoprotein receptor pathway in normal human fibroblast. J. Biol. Chem. 258:1983;4526-4533.
9. Glenner G.G., Wong C.W. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120:1984;885-890.
10. Golabek A.A., Soto C., Vogel T., Wisniewski T. The interaction between apolipoprotein E and Alzheimer's amyloid β-peptide is dependent on β-peptide conformation. J. Biol. Chem. 271:1996;10602-10606.
11. Hixson J.E., Vernier D.T. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J. Lipid Res. 31:1990;545-548.
12. Ignatus M.J., Gebicke-Härter P.J., Pate Skene J.H., Schilling J.W., Weisgraber K.H., Mahley R.W., Shooter E.M. Expression of apolipoprotein E during nerve degeneration. Proc. Natl. Acad. Sci. USA. 83:1986;1125-1129.
13. Ishii T., Haga S. Immuno-electron-microscopic localization of complements in amyloid fibrils of senile plaques. Acta Neuropathol. 63:1984;296-300.
14. Jarret J.T., Berger E.P., Lansbury P.T. Jr. The carboxy terminus of the β amyloid protein is critical for the seeding of amyloid formation: implication for the pathogenesis of Alzheimer's disease. Biochemistry. 32:1993;4693-4697.
15. Kang J., Lemaire H.G., Unterbeck A., Salbaum J.M., Masters C.L., Grzeschik K.H., Multhaup G., Beyreuther K., Muller-Hill B. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell surface receptor. Nature. 325:1987;733-736.
16. LaDu M.J., Falduto M.T., Manelli A.M., Reardon C.A., Getz G.S., Frail D.E. Isoform-specific binding of apolipoprotein E to β-amyloid. J. Biol. Chem. 269:1994;23403-23406.
17. LaDu M.J., Pederson T.M., Frail D.E., Reardon C.A., Getz G.S., Falduto M.T. Purification of apolipoprotein E attenuates isoform-specific binding to beta-amyloid. J. Biol. Chem. 270:1995;9039-9042.
18. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
19. Mahley R.W. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 240:1988;622-630.
20. Mann D.M.A., Esiri M.M. The site of the earliest lesions of Alzheimer's disease. New Engl. J. Med. 318:1988;789-790. Letter.
21. Masters C.L., Simms G., Weideman N.A., Multhaup G., McDonald B.L., Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl. Acad. Sci. USA. 82:1985;4245-4249.
22. Namba Y., Tomonaga M., Kawasaki H., Otomo E., Ikeda K. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res. 541:1991;163-166.
23. Poirier J., Hess M., May P.C., Finch C.E. Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning. Mol. Brain Res. 11:1991;97-106.
24. Saunders A.M., Strittmatter W.J., Schmechel D., St George-Hyslop P.H., Pericak-Vance M.A., Joo S.H., Rosi B.L., Gusella J.F., Crapper-MacLachlan D.R., Alberts M.J., Hulette C., Crain B., Goldgaber D., Roses A.D. Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 43:1993;1467-1472.
25. Schmechel D.E., Saunders A.M., Strittmatter W.J., Crain B.J., Hulette C.M., Joo S.H., Pericak-Vance M.A., Goldgaber D., Roses A.D. Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc. Natl. Acad. Sci. USA. 90:1993;9649-9653.
26. Selkoe D.J., Podlisny M.B., Joachim C.L., Vickers E.A., Lee G., Fritz L.C., Oltersdorf T. β-Amyloid precursor protein of Alzheimer disease occurs as 110- to 135-kilodalton membrane-associated proteins in neural and nonneural tissues. Proc. Natl. Acad. Sci. USA. 85:1988;7341-7345.
27. Soto C., Golabek A., Wisniewski T., Castano E.M. Alzheimer's beta-amyloid peptide is conformationally modified by apolipoprotein E in vitro. Neuroreport. 7:1996;721-725.
28. Stoll G., Muller H.W., Trapp B.D., Griffin J.W. Oligodendrocytes but not astrocytes express apolipoprotein E after injury of rat optic nerve. Glia. 2:1989;170-176.
29. Strittmatter W.J., Weisgraber K.H., Huang D.Y., Dong L.-M., Salvesen G.S., Pericak-Vance M., Schmechel D., Saunders A.M., Goldgaber D., Roses A.D. Binding of human apolipoprotein E to synthetic amyloid β peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc. Natl. Acad. Sci. USA. 90:1993;8098-8102.
30. Takamaru Y. Analysis of the 80 kDa antigen in senile plaque amyloid. Hokkaido Med. J. 69:1994;191-201. in Japanese.
31. Takamaru Y., Fukatsu R., Tsuzuki K., Aizawa Y., Nagasawa S., Chiba H., Kobayashi K., Fujii N., Koyama T., Takahata N. Apolipoprotein E in senile plaque. Jpn. J. Geriat. Psychiatry. 6:1995;1129-1137. in Japanese.
32. Wisniewski T., Frangione B. Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci. Lett. 135:1992;235-238.
33. Wisniewski T., Lalowski M., Golabek A., Vogel T., Frangione B. Is Alzheimer's disease an apolipoprotein E amyloidosis? Lancet. 345:1995;956-958.
34. Yang D.S., Smith J.D., Zhou Z., Gandy S.E., Martins R.N. Characterization of the binding of amyloid-β peptide to cell culture-derived native apolipoprotein E2, E3 and E4 isoforms and to isoforms from human plasma. J. Neurochem. 68:1997;721-725.
35. Zhou Z., Smith J.D., Greengard P., Gandy S. Alzheimer amyloid-beta peptide forms denaturant-resistant complex with type epsilon 3 but not type epsilon 4 isoform of native apolipoprotein E. Mol. Med. 2:1996;175-180.